Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Monthly Archives: January 2011
MSF Statement: Johnson & Johnson/ Tibotec AIDS Drug Licenses Leave Out Too Many Patients
Geneva, 28 January 2011 – Licenses just agreed between three generic manufacturers and pharmaceutical company Tibotec, owned by Johnson & Johnson, will keep a promising new AIDS medicine out of the hands of many patients across the developing world, the … Continue reading
Posted in Other
Tagged Generic drug, HIV/Aids, Médecins Sans Frontières, Pharmaceutical industry
1 Comment
J&J Generics Deal May Speed AIDS Drug Access in Africa, India
January 28, 2011, Bloomberg Business Week By Alex Nussbaum Jan. 28 (Bloomberg) — Johnson & Johnson struck the first deal to license an experimental AIDS drug before regulatory approval, reigniting debate over how much companies should do to speed access … Continue reading
Posted in Other
Leave a comment
Press: India, EU FTA issues – officials to meet this week
Source: SME Times, 28.1.2011 The chief officials of India and the European Union will hold meetings this week, in Kerala, to resolve their differences and to conclude talks on a proposed market opening pact by April. India’s chief negotiator, Commerce … Continue reading
Trade Invaders- India EU Free Trade Negotiations
Countercurrents.org, 26.1.2011, by Syed Ali Mujtaba At a time when the entire nation’s attention is focused on different scams that’s hogging the media headlines, little attention is being paid to the new trade deal negotiated between India and the European … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, India, World Trade Organization
Leave a comment
Press: Data exclusivity still key hurdle to India-EU FTA
Source: Business Standard, 27.01.2011, by Nayanima Basu & Joe C Mathew Despite all official assurances, the path towards a free trade agreement (FTA) between India and the European Union (EU) this year remains ambiguous, as both sides are unwilling to … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, India, World Trade Organization
Leave a comment
Press: IPA concerned over PMO’s efforts to destabilize India’s IPR regime at the behest of EU
Source: Pharmabiz, 27.1.2011, by Ramesh Shankar The Indian Pharmaceutical Alliance (IPA), an association of leading Indian pharma companies, has raised alarm over the recent media reports that efforts are going on in the Prime Ministers Office (PMO) to destabilize India’s … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, India, TRIPS, World Trade Organization
Leave a comment
DNP+ letter to WHO on impact study on IP provisions in the India-EU FTA
WHO’s impact study on IP provisions in the India-EU FTA Dear Dr. Plianbangchang, I am writing on behalf of the Delhi Network of Positive People (DNP+). Our organization was founded in 1999 as a support group of people living with … Continue reading
Posted in EU-India FTA, Letters to officials
Tagged DNP+, EU, FTA, Generic drug, HIV/Aids, India, Intellectual property, TRIPS
Leave a comment
India, EU negotiators to meet in Kerala to resolve FTA issues
25 JAN, 2011,PTI NEW DELHI: The chief negotiators of India and the European Union will hold meetings at the Kumarakom lake resort, in Kerala , this week with the aim of resolving their differences and concluding talks on a proposed … Continue reading
Posted in Uncategorized
Leave a comment
Press: Natco may seek compulsory licence for Bayer’s cancer drug
Source: Economic Times, 24.1.2011, by Khomba Singh NEW DELHI: Natco Pharma plans to seek a compulsory licence from the government to make Bayer AG’s Nexavar in India, invoking a provision in local laws that allows generic drugmakers to make and … Continue reading
Posted in Compulsory Licensing
Tagged Compulsory license, Generic drug, India, Patent
Leave a comment
IP Watch: ACTA Inconsistent With European Law, Legal Experts Say
Source: IP Watch, 23.1.2011, by Monika Ermert The recently completed Anti-Counterfeiting Trade Agreement (ACTA) is not fully consistent with European Union law and goes beyond international law in some of its aspects, concluded a group of intellectual property law experts … Continue reading
